A Facile and Efficient Protocol for the Construction of Oxime Esters from Carboxylic Acids and Evaluation of Their Antimicrobial Activities

24 Available online at www.derpharmachemica.com ISSN 0975-413X CODEN (USA): PCHHAX Der Pharma Chemica, 2023, 15(4): 24-31 (http://www.derpharmachemica.com/archive.html) A Facile and Efficient Protocol for the Construction of Oxime Esters from Carboxylic Acids and Evaluation of Their Antimicrobial Activities Berihu Tekluu1* and Siddaiah Vidavalur2 1Aksum University Department of Chemistry, Aksum, Ethiopia 2Department of Organic Chemistry and FDW, College of Science and Technology, Andhra University, Visakhapatnam, Andhra Pradesh, India *Corresponding author: Berihu Tekluu, Aksum University Department of Chemistry, Aksum, Ethiopia., E-mail: [email protected] Received: 03-Apr-2023, Manuscript no: dpc-23-96175, Editor assigned: 05-Apr-2023, PreQC No: dpc-23-96175, Reviewed: 19-Apr-2023, QC No: dpc-23-96175, Revised: 21-Apr-2023, Manuscript No: dpc-23-96175 Published: 28-Apr-2023, DOI: 10.4172/0975-413X.15.4.24-31 ABSTRACT A facile and efficient protocol for the synthesis of various structurally and electronically divergent oxime esters from carboxylic acids and oximes in the presence of 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) and N-methylmorpholine (NMM) in 1,4-dioxane in high yields (90-97%). The synthesized compounds were assessed for their antimicrobial activities. Among the tested compounds 3d, 3j and 3p showed good antimicrobial activity. Keywords: Oxime esters; Oximes; CDMT; NMM; Carboxylic acids INTRODUCTION Oxime esters and their derivatives have been shown to have favorable attracting attention from researchers, since compounds bearing oxime ester group are valued not only for their rich and varied chemistry, but also for many important biological properties. Oxime esters are one of the most important and versatile intermediates in organic synthesis. They are very attractive starting materials for the synthesis of various nitrogen and oxygen containing compounds including amine and its derivatives [1], nitriles [2], hetero aromatics such as indoles [3], pyrroles [4], pyridines [5], quinoline derivatives [6] etc. The oxime ester moiety is a privileged group in chemistry due to its presence in a large number of medicinal scaffolds that exhibit a broad range of biological and pharmaceutical properties, such as antibacterial [7], anticonvulsant [8], insecticidal [9], antitumor [10], antiproliferative [11], herbicidal [12], antioxidant and antimicrobial [13], antifungal [14-16], anticancer [17,18] antiviral [19] activities. Some oxime esters have recently been reported to exhibit DNA-cleaving ability by using photolysis process [20,21]. Moreover, they can be used as intermediates for the synthesis of peptides [22] and fragrances [23] (Figures 1,2). 25 Berihu Tekluu, et al Der Pharma Chemica, 2023, 15(4): 24-31 S O NO O O N NO O OXE-1 OXE-2 12 Figure 1: Photo active oximes NN O O Ph HO OMe HO OMe O OMe N O O Me NN N O O O F3C O O NSN H O F3C O O O N 5 4 3 67 Figure 2: Examples of oxime esters containing antioxidant 3, antifungal 4, insecticide 5, antiinflammatory 6 and herbicide 7 activities Owing to their important applications, various methods have been developed for the synthesis of oxime esters. Generally, oxime esters are synthesized by the reaction of oximes with activated carboxylic acids using basic or acidic conditions [24] or with carboxylic acids using coupling reagents like EDC [25]. Recently, benzoyl esters of alkyl and aryl substituted oximes have been prepared using benzoyl peroxide, [26] but it is applicable mainly to benzoyl esters of oximes. Very recently, oxime esters also prepared from α,β-unsaturated aldehydes and oximes using a Nheterocyclic carbine as a catalyst [27]. However, these methods have some drawbacks such as use of expensive catalysts and harsh reaction conditions. Therefore, developing a mild and more general procedure to access oxime esters is still highly desirable. Cyanuric chloride or its derivatives have received considerable attention as easily available and inexpensive catalysts for various transformations [28]. 2-Chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) is commercially available, stable and can also be prepared from commercially available and inexpensive cyanuric chloride. It has been found to have applications as a condensing reagent in peptide chemistry [29] and used for the in situ activation of the carboxylic group in many transformations, such as the synthesis of N-methoxy-N-methyl amides, [30] aldehydes, ketones or αamino ketones, [31] 2-oxazolines [32] and monoacylated piperazines [33]. Thus, in continuation of our work on the development of efficient new synthetic methodologies for heterocyclic compounds, herein, we describe an efficient method for the synthesis of oxime esters from carboxylic acids and oximes using CDMT and NMM in 1,4-dioxane at reflux conditions (Scheme 1). N N N OMe ClMeO NMM, 1,4-Dioxane R3COOH (2), r.t., 30 min N N N OR3 O OMe OMe R1R2 NOH 1,4-Dioxane, reflux R3O ON R1 R2 (1) 3a-r Scheme 1: Construction of oxime esters from carboxylic acids and acetphenone oxime RESULTS AND DISCUSSION In the standard procedures, first the CDMT reacts with N-methylmorpholine (NMM) to form 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4methylmorpholinium chloride (DMTMM), and then the carboxylic acid is added to generate an active ester. This activated ester was further treated with oxime to afford the oxime esters. In a model study, benzoic acid (2a) was treated with CDMT and NMM in dichloromethane at room temperature. The corresponding activated ester was quantitatively formed after 30 min (monitored by TLC). This white suspension containing the activated ester was subsequently treated with acetphenone oxime (1a) at reflux conditions. We were delighted to observe the formation of the 26 Berihu Tekluu, et al Der Pharma Chemica, 2023, 15(4): 24-31 desired product 3a, albeit in a low yield of 60% after 12 h (Table 1, entry 1). Then, we optimized the reaction conditions to increase the yield of the product and to reduce the reaction time. Thus, we investigated the effect of various solvents such as DCM, THF, 1,4-dioxane and CH3CN on the model reaction (Table 1, entries 2-5). Among the tested solvents, 1,4-dioxane gave the best result. But, other solvents were not as sufficient for this purpose. Furthermore, the by-products formed were removed by a simple aqueous workup, and the desired oxime esters were purified by silica gel column chromatography and the compounds were characterized by advanced spectroscopic analysis 1H NMR, 13C NMR and MS (Tables 1,2). OH O CDMT/ NMM Solvent, reflux O O N 1a 2a 3a N + OH Table 1: Effect of various solvents in the synthesis of 3aa. Entry Solvent Time /h Yieldb / % 1 CH2Cl2 12 60 2 CHCl3 14 55 3 THF 10 48 4 1,4dioxane 6 95 5 CH3CN 15 55 Table 2: Synthesis of alkyl and aryl oxime esters using CDMT/NMM in 1,4-dioxane at reflux conditionsa. Entry Oxime Carboxylic acid Product Yield (%)b 1 NOH 1a O OH 2a O ON 3a 95 2 1a O OH 2b O ON 3b 91 3 1a O OH H2N2c O ON H2N3c 90 4 1a O OH Cl 2d O ON Cl 3d 93 5 1a O OH O2N 2e O ON O2N3e 95 27 Berihu Tekluu, et al Der Pharma Chemica, 2023, 15(4): 24-31 6 1a Pr O OH 2f Pr O ON 3f 93 7 NOH 1b 2a O ON 3g 96 8 1b 2b O ON 3h 96 9 1b 2c O ON 3i H2N 92 10 1b 2d O ON 3j Cl 95 11 1b 2e O ON 3k O2N 94 12 1b 2f O ON 3l Pr 97 13 NOH 1c 2a O ON 3m 92 14 1c 2b O ON 3n 95 15 1c 2c O ON 3o H2N 91 28 Berihu Tekluu, et al Der Pharma Chemica, 2023, 15(4): 24-31 16 1c 2d O ON 3p Cl 93 17 1c 2e O ON 3q O2N 94 18 1c 2f Pr O ON 3r 97 aReaction conditions: 1a (0.5 equiv.), 2a (1.0 equiv.), CDMT (1 equiv.), NMM (3 equiv.) 1,4-dioxane (5mL) at 50 °C, bIsolated yields. With the optimized conditions in hand, the scope of the reaction substrates was investigated and the results are summarized in Table 2. From Table 2, it is clear that this method is highly efficient and useful for aromatic carboxylic acids with either electron-donating or electron-withdrawing substituents on the aryl residue. It is noteworthy that aliphatic carboxylic acid such as butyric acid was completely converted into the corresponding oxime ester in good yields (Table 2, entry 6). Next, different oximes were investigated as the reaction substrates (Table 2). As expected, the oximes such as phenyl acetophenone oxime, benzophenone oxime and cyclohexanone oxime reacted smoothly and produced the corresponding oxime esters in excellent yields (Table 2). All the compounds were characterized by advanced spectroscopic analysis (1HNMR, 13CNMR, and MS). Biological activities Antimicrobial activity All the synthesized compounds 3a-3q were evaluated for antibacterial activities against Bacillus subtilis (MTCC 8141), Staphylococcus aureus (MTCC 7443), Escherichia coli (MTCC 6365) and Proteus vulgaris (NCIM 2813). To carry out the antimicrobial activity (zone of inhibition), we used standard solution of 100 µg/ml. The results obtained as zone of inhibition (mm) are presented in Table 3 and their minimum inhibitory concentration (MIC) values against these microorganisms were determined by serial dilution method and results are presented in Table 4. It is more attractive to speculate the observation that the result of the antimicrobial activity of the different derivatives of oxime esters appeared to be related to the nature of substituent on the phenyl unit. All the tested compounds found to be active against both gram positive and gram negative bacteria, they exhibited zone of inhibition ranging from 8.1 to 23 mm. Among the tested compounds, 3d, 3j and 3p are more active against two bacterial strains; Staphylococcus aureus (MTCC 7443) and Escherichia coli (MTCC 6365) than all other, 3d, 3j and 3p possessing chloro group at para position in phenyl moiety to ester ring. Compounds bearing nitro group exhibited slightly less antibacterial activity than standard. Compounds bearing methyl and amino groups were demonstrated to have moderate activity against all tested bacterial strains. The compounds 3a and 3g which are having no substitution on aryl ester moiety exhibited least antibacterial activity (Tables 3,4). Table 3: Zone of inhibition (mm) against bacteria. Compound No. Zone of inhibition (mm) B. subtilis S. aureus E. coli P. vulgaris 3a 9.2 11.1 8.1 10.1 3b 15 17.8 16 12.5 3c 16 18 17.5 13.3 3d 18.3 23 21 17.8 3e 14 14.3 13 11.2 29 Berihu Tekluu, et al Der Pharma Chemica, 2023, 15(4): 24-31 3g 8.5 9.3 8 9.2 3h 15 18 17.3 12 3i 14.5 15 13.8 12.5 3j 17.3 19.5 19.2 16 3k 15 16 15 11.1 3m 9.3 11.8 8.5 10.4 3n 14 16.2 14.9 12.3 3o 15 18 18 13.9 3p 18.4 20 17 16.7 3q 15.3 16.5 15.2 11.3 Amoxycillin 24.5 32.8 31.6 29.3 DMF -- -- -- -- *Average of three readings B. s = Bacillus subtilis (MTCC 8141); S. a = Staphylococcus aureus (MTCC 7443); E. c = Escherichia coli (MTCC 6365); P. v = Proteus vulgaris (NCIM 2813) Table 4: Minimum Inhibitory Concentration (MIC) values of the tested compounds against various bacteria. Compound No. *MIC values in μg/ml B. s S. a E. c P. v 3a 50 100 100 50 3b 50 100 100 50 3c 25 100 100 50 3d 50 100 100 50 3e 25 50 100 50 3g 50 100 100 50 3h 50 100 100 50 3i 50 25 100 100 3j 25 50 100 100 3k 25 50 100 50 3m 50 100 100 50 3n 50 100 100 50 3o 50 25 100 100 3p 25 50 100 100 3q 25 50 100 50 Amoxycillin 100 100 100 100 DMF -- -- -- -- *Average of three readings B. s = Bacillus subtilis (MTCC 8141); S. a = Staphylococcus aureus (MTCC 7443); E. c = Escherichia coli (MTCC 6365); P. v = Proteus vulgaris (NCIM 2813) 30 Berihu Tekluu, et al Der Pharma Chemica, 2023, 15(4): 24-31 EXPERIMENTAL General experimental procedure for the synthesis of alkyl and aryl oxime esters (3a-r) To a stirred solution of CDMT (2.279 mmol) in 1, 4-dioxane (5 mL), NMM (6.837 mmol) was added drop wise and allowed to stir for 5 min. To the white suspension containing 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium solution of carboxylic acid (2.279 mmol) in 1,4-dioxane (5 mL) was added and stirred at room temperature for 30 min. Then a solution of oxime (1.025 mmol) in 1,4-dioxane added to the above reaction mixture and stirred at reflux. After the completion of the reaction (as monitored by TLC), the reaction mixture was cooled to room temperature, aq. 5% Na2CO3 solution was added and extracted with ethyl acetate. The organic layer was separated and dried over anhydrous sodium sulphate and concentrated under vacuum to afford the crude compound. The crude compound was purified with silica gel column chromatography using hexane/EtOAc as eluents to afford the pure product. The data for some oxime esters (Table 2, Entries 4, 10 and 16) is given below. Acetophenone O-4-Chlorobenzoyl Oxime (3d) White solid; Yield: 93%; Mp: 102-104 oC; 1H NMR (400 MHz, CDCl3): δ 8.07 (d, 2H), 7.82-7.80 (d, 2H), 7.46 (d, 5H), 2.51 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 163.8, 162.9, 149.1, 139.8, 134.7, 131.0, 130.7, 128.9, 128.6, 127.1, 14.7; LC-MS: m/z = 296 [M+Na]+; Anal. Calcd for C15H12ClNO2Na: C, 65.82; H, 4.42; N, 5.12. Found: C, 65.79; H, 4.46; N, 5.09 Cyclohexanone O-4-Chlorobenzoyl Oxime (3j) White solid; Yield: 95%; Mp: 108-110 oC; 1H NMR (400 MHz, CDCl3): δ 7.90 (d, 2H), 7.34 (d, 2H), 2.38 (d, 4H), 1.64 (m, 6H); 13C NMR (100 MHz, CDCl3): δ 169.8, 163.4, 139.6, 130.9, 128.8, 127.8, 32.2, 29.7, 27.1, 25.4; LC-MS: m/z = 274 [M+Na]+; Anal. Calcd for calcd for C13H14ClNO2Na: C, 62.03; H, 5.61; N, 5.56. Found: C, 61.98; H, 5.67; N, 5.53 Benzophenone O-4-Chlorobenzoyl Oxime (3p) White solid; Yield: 93%; Mp: 110-112 oC; 1H NMR (400 MHz, CDCl3): δ 7.73-7.68 (d, 2H), 7.60 (d, 2H), 7.52 (d, 2H), 7.48-7.46 (d, 2H), 7.41 (d, 3H) 7.40 (d, 3H); 13C NMR (100 MHz, CDCl3): δ 165.85, 162.95, 139.74, 134.45, 132.75, 131.15, 130.98, 129.76, 129.13, 128.86, 128.72, 128.48, 128.33, 127.25; LC-MS: m/z = 358 [M+Na]+; Anal. Calcd for C20H14ClNO2Na: C, 71.54; H, 4.20; N, 4.17. Found: C, 71.50; H, 4.23; N, 4.11 CONCLUSION In conclusion, we synthesized new one pot protocol for the convenient synthesis of alkyl and aryl oxime esters from the carboxylic acids and oximes in the presence of 2-chloro-4, 6-dimethoxy-1,3,5-triazine (CDMT) and N-methylmorpholine (NMM) in 1,4-dioxane in high yields (9097%). The synthesized compounds were assessed for their antimicrobial activities. All the tested compounds found to be active against both gram positive and gram negative bacteria, they exhibited zone of inhibition ranging from 8.1 to 23 mm. Among the tested compounds 3d, 3j and 3p showed good antimicrobial activity. There for it is confirmed that the synthesized compounds are capable of rendering significant antimicrobial activities ACKNOWLEDGMENTS The authors thank Aksum University and the Ministry of Education, Ethiopia, for financial support to B. T. G. Supporting information Full experimental details and 1H, 13C NMR and mass spectra can be accessed on the publisher’s website. Conflicts of Interest The Authors declare that they have no conflicts of interest. REFERENCES [1] Feuer H, Braunstein DM. J Org Chem. 1969, 34: p. 1817. [2] Fujii, A, Satoshi S, Yasutaka I. J Org Chem. 2000, 65: p. 6209. [3] Tan, Yichen, John F. Hartwig. J Am Chem Soc. 2010, 132: p. 3676. [4] Senadi GC, Lu TY, Dhandabani GK. J Org Lett. 2017, 19: p. 1172. [5] Neely JM, Tomislav R. Tetrahedron Lett. 1984, 25: p. 3887. [6] Zhang, Zhi-Wei, Aijun Lin, et al., J Org Chem. 2014, 79: p. 7041. [7] Liu XH, Zhi LP, Song BA, et al., Chem Res Chin Univ. 2008, 24: p. 454. [8] Karakurt A, Alagöz MA, Sayoglu B, et al., Eur J Med Chem. 2012, 57: p. 275. [9] Liu C, Zhang J, Zhou Y, et al., Chem Res Chin Univ. 2014, 30: p. 228. [10] Stefan V, Kathleen P, Muriel P, et al., Helv Chim Acta. 1999, 82: p. 963. [11] Surkau G, Böhm KJ, Müller K, et al., Eur J Med Chem. 2010, 45: p. 3354. [12] Li TG, Liu JP, Han JT, et al., Chin J Org Chem. 2009, 29: p. 898. [13] Harini ST, Kumar HV, Peethambar SK, et al., Med Chem Res. 2014, 23: p. 1887. 31 Berihu Tekluu, et al Der Pharma Chemica, 2023, 15(4): 24-31 [14] Wang D. Chem Biodiver. 2014, 11: p. 886. [15] Harini, Salakatte T. Bioorg Med Chem Lett. 2012, 22: p. 7588. [16] Krishnan GK, Sivakumar R, Thanikachalam V. J Serbian Chem Soc. 2015, 80: p. 1101. [17] Song, Bao‐An. Chin J Chem. 2005, 23: p. 1236. [18] Tang, Jiang-Jiang, Gang Li, et al., Arabian J Chem. 2015, 1. [19] Ouyang G, Chen Z, Cai XJ, et al., Bioorg Med Chem. 2008, 16: p. 9699. [20] Bachovchin DA, Wolfe MR, Masuda K, et al., Bioorg Med Chem Lett. 2010, 20: p. 2254. [21] Hwu JR, Tsay SC, Hong S, et al., Bioconjugate Chem. 2013, 24: p. 1778. [22] Zhukovskaya NA, Dikusar EA, Potkin VI, et al., Chem Nat Comp. 2009, 45: p. 148. [23] Hayashi I, Shimizu K. Bull Chem Soc Jpn. 1983, 56: p. 3197. [24] Dikusar EA, Zhukovskaya NA. Russ J Org Chem. 2008, 44: p. 1389. [25] Kumar SCS, Kumar NV, Srinivas P, et al., Synthesis. 2014, 46: p. 1847. [26] Kundu SK, Rahman M, Dhara P, et al., Synth Commun. 2012, 42: p.1848. [27] Enders D, Grossmann A, Van C. Org Biomol Chem. 2013, 11: p. 138. [28] De LL, Giacomelli G, Porcheddu A. J Org Chem. 2002, 67: p. 6272. [29] Kamiński ZJ. Biopolymers. 2000, 55: p. 140. [30] De LL, Giacomelli G, Taddei M. J Org Chem. 2001, 66: p. 2534. [31] De LL, Giacomelli G, Porcheddu A. Org Lett. 2001, 3: p. 1519. [32] Bandgar BP, Pandit SS. Tetrahedron Lett. 2003, 44: p. 2331. [33] Bandgar BP, Pandit SS. Tetrahedron Lett. 2003, 44: p. 3855.